ENDRA Life Sciences Inc. NDRA
6.04
0.11
1.85%
as of 25 Sep
- Market cap
- $8.9M
- P/E
- 0.0×
Follow NDRA
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
7.04 | 0.43 | 1.02 | 0.99 | |
Current Ratio |
7.10 | 0.64 | 1.29 | 1.31 | |
Net Debt/EBITDA |
3.84 | 0.17 | 0.48 | 0.60 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(5.80) | 0.85 | 0.51 | 0.73 | |
Capex/Depreciation |
(0.48) | 0.00 | (75.95) | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.70) | (0.93) | (2.05) | (1.53) | |
Capex per Share |
(0.01) | 0.00 | (3.81) | 0.00 | |
Free Cash Flow per Share |
(0.71) | (0.93) | (5.86) | (1.53) | |
Cash per Share |
4.18 | 0.30 | 0.97 | 1.04 | |
Shareholders Equity per Share |
4.77 | 1.49 | 2.87 | 0.23 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
4.77 | 1.49 | 2.87 | 0.23 | |
Free Cash Flow |
(0.95) | (1.12) | (4.61) | (1.16) | |
Working Capital |
4.80 | (0.30) | 0.22 | 0.25 | |
Capital Expenditures |
(0.02) | — | (3.00) | 0.00 | |
Net Current Asset Value |
3.95 | (1.11) | (0.63) | (0.74) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
0.55 | 0.57 | 0.56 | 0.65 | |
Average Assets |
5.37 | 3.30 | 4.15 | 5.17 | |
Average Common Equity |
3.89 | 1.77 | 2.41 | 3.39 |
Columns are period end dates